Optimization of Health Expenditure in Liver Surgery

NCT ID: NCT01715402

Last Updated: 2017-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to reduce the length of stay after liver surgery by taking account of objective quantitative clinical variables, subjective qualitative clinical variables and non clinical variables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

a new dimension of the activity expected of physicians is to improve the safety of care on the one hand and the control of health care costs on the other.

key measures to help them are the publication of national recommendations, assessment of actual practices and the incentive to activity.

Internationalwide recent and concordant data suggest that

* quality and security of care, after an initial improvement, are going to stall
* scientific recommendations are rarely validated by an impact analysis and are not applied
* clinical data collected within an administrative framework are unreliable and too generalist
* the evaluation, especially in the surgical field, is based on indicators sometimes irrelevant and often unclear

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocellular Carcinoma Hilar Cholangiocarcinoma Intra Hepatic Cholangiocarcinoma Liver Metastasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

operated patients

this cohort includes patients who underwent a liver surgery whatever the pathology and whatever the surgical procedure

liver surgery

Intervention Type PROCEDURE

this intervention type includes hepatectomies; wedge; segmentectomies etc...

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

liver surgery

this intervention type includes hepatectomies; wedge; segmentectomies etc...

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective liver surgery
* older than 18
* agreed to participate
* surgical procedure included procedures registered as "HLFA003 - 007 ; 009 - 011 ; 017 - 020 ; HLFC002 à 004 ; 027 ; 032 ; 037" in the PMSI database

Exclusion Criteria

* emergency surgery
* refused to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier FARGES, MD, phD

Role: PRINCIPAL_INVESTIGATOR

Beaujon University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amiens North Hospital

Amiens, , France

Site Status

Bordeaux Hospital

Bordeaux, , France

Site Status

Beaujon University Hospital

Clichy, , France

Site Status

Lille Regional Hospital

Lille, , France

Site Status

Lyon Hospital

Lyon, , France

Site Status

Marseille Hospital

Marseille, , France

Site Status

Paoli calmette institute

Marseille, , France

Site Status

Saint Antoine Hospital

Paris, , France

Site Status

Strasbourg hospital

Strasbourg, , France

Site Status

Gustave Roussy institute

Villejuif, , France

Site Status

Paul Brousse Hospital

Villejuif, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cauchy F, Farges O, Vibert E, Boleslawski E, Pruvot FR, Regimbeau JM, Mabrut JY, Scatton O, Adham M, Laurent C, Gregoire E, Delpero JR, Bachellier P, Soubrane O. Sensitizing Surgeons to Their Outcome Has No Measurable Short-term Benefit. Ann Surg. 2017 Nov;266(5):884-889. doi: 10.1097/SLA.0000000000002403.

Reference Type DERIVED
PMID: 28991876 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AOM 11060

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.